ACS Global, Inc.
Limited financial coverage for AMCY.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
ACS Global, Inc. specializes in the acquisition, meticulous processing, and secure, long-term cryogenic storage of stem cells. The company enables individuals to privately bank their own stem cells for potential future applications in cellular therapy.
- CEO
- Anthony Francis Dudzinski Jr.
- IPO
- 2021
- HQ
- Red Bank, NJ, US
Get TickerSpark's AI analysis on AMCY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $3.00
- 52W Low
- $3.00
- 50D MA
- $3.00
- 200D MA
- $3.00
- Beta
- 0.00
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for AMCY yet.
- Free Float
- 0.0%
- Shares Outstanding
- 57.09M
- Float Shares
- 0
Our AMCY coverage
Recent articles, reports, and earnings notes.
No research on AMCY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMCY report →